Cadrenal Therapeutics Inc Stock (CVKD) Forecast
The Cadrenal Therapeutics Inc (CVKD) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.35, representing a +310.71% increase from the current price of $1.06. The highest analyst price target is $8.33, and the lowest is $0.3723.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CVKD Price Target
Average 14.18 (+1,237% Upside)
Is Cadrenal Therapeutics Inc (CVKD) A Buy Now?
Oscillators
Buy: 1 · Sell: 0 · Neutral: 6Summary: Neutral
Moving Averages
Buy: 4 · Sell: 6 · Neutral: 0Summary: Sell
According to our latest analysis, CVKD could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on CVKD, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 51.32 indicates that CVKD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 53.28 indicates that CVKD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 69.91 indicates that CVKD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of 16.32 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of 59.77 indicates that CVKD is still overbought but not to an extreme extent.
Long-term CVKD price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cadrenal Therapeutics Inc financial reports and earnings history, Cadrenal Therapeutics Inc (CVKD) stock could reach $18.83 by 2030, $57.22 by 2040 and $35.90 by 2050. See the projected annual prices until 2050 of the Cadrenal Therapeutics Inc stock below:
- Cadrenal Therapeutics Inc (CVKD) is expected to reach an average price of $32.41 in 2035, with a high prediction of $44.34 and a low estimate of $1.27. This indicates an +2,957% change from the last recorded price of $1.06.
- Cadrenal Therapeutics Inc (CVKD) stock is projected to chart a bullish course in 2040, with an average price target of $29.18, representing an +2,653% change from its current level. The forecast ranges from a conservative $30.83 to a sky-high $57.22.
- Our analysts predict Cadrenal Therapeutics Inc (CVKD) to change +2,255% by 2045, soaring from $27.36 to an average price of $24.96, potentially reaching $46.31. While $27.36 is the low estimate, the potential upside is significant.
- Cadrenal Therapeutics Inc (CVKD) stock is expected to climb by 2050, reaching an average of $15.93, a +1,403% change from its current level. However, a wide range of estimates exists, with high and low targets of $35.90 and $15.92, respectively, highlighting the market's uncertainty.
Cadrenal Therapeutics Inc Stock (CVKD) Year by Year Forecast
Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2026
The predicted value for Cadrenal Therapeutics Inc (CVKD) in 2026 is set at an average of $3.65. Estimates vary from a peak of $8.96 to a trough of $0.3723, indicating an +244.19% surge from the present price of $1.06.
Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cadrenal Therapeutics Inc (CVKD) is $6.41, with a high forecast of $28.34 and a low forecast of $0.0109. This indicates an +504.43% increase from the last price of $1.06.
Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2028
In 2028, Cadrenal Therapeutics Inc (CVKD) is projected to reach an average price of $5.80, with a high projection of $10.27 and a low estimate of $0.4111. This indicates an +447.32% rise from the last price of $1.06.
Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2029
The 2029 price forecast for Cadrenal Therapeutics Inc Stock (CVKD) is $5.29 on average, with a high prediction of $12.84 and a low estimate of $0.7932. This represents an +398.69% increase from the previous price of $1.06.
Cadrenal Therapeutics Inc Stock (CVKD) Price Forecast for 2030
Cadrenal Therapeutics Inc Stock (CVKD) is expected to reach an average price of $2.57 in 2030, with a high forecast of $18.83 and a low forecast of $0.000373. This signifies an +142.59% surge from the last price of $1.06.
